Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) from the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program
Authors: Brett King, Jennifer Soung, Christos Tziotzios, Lidia Rudnicka, Pascal Joly, Melinda Gooderham, Rodney Sinclair, Susan D. Anway, Dalia Wajsbrot, Alexandre Lejeune, Samuel H. Zwillich
Comments